Kim, Se-Min
Sultana, Farhath
Korkmaz, Funda
Rojekar, Satish
Pallapati, Anusha
Ryu, Vitaly
Lizneva, Daria
Yuen, Tony
Rosen, Clifford J.
Zaidi, Mone
Funding for this research was provided by:
National Institute on Aging (R01AG071870, R01AG074092, U01AG073148, U19AG060917)
Article History
Accepted: 26 July 2024
First Online: 3 August 2024
Declarations
:
: M.Z. is inventor on issued and pending patents on the use of FSH as a target for osteoporosis, obesity and Alzheimer’s disease. M.Z., T.Y. and S.R. are inventors on a pending patent on the formulation of a monoclonal antibody against FSH. The patents will be held by Icahn School of Medicine at Mount Sinai, and M.Z, T.Y. and S.R. would be recipients of royalties, per institutional policy, should the patents be granted. The other authors declare no competing financial interests.